Back

ESC TV Interview - ADVOR - Acetazolamide in acute heart failure.

1 December 2022 (16:06 - 16:08)
Organised by:
Congress Presentation Part of: Hot Line: Heart Failure Chronic Heart Failure ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

8 More presentations in this session

Presentation thumbnail
ESC TV Interview - DELIVER - Dapagliflozin in Heart Failure with Mildly Reduced and Preserved Ejection Fraction.
Video
Presentation thumbnail
DELIVER - Dapagliflozin in Heart Failure with Mildly Reduced and Preserved Ejection Fraction.
Professor C. Lam (Singapore, SG)
Video
Presentation thumbnail
ESC TV Interview - Pooled analysis of DAPA-HF and DELIVER.
Video
Presentation thumbnail
Pooled analysis of DAPA-HF and DELIVER.
Associate Professor D. Sim (Singapore, SG)
Video
Presentation thumbnail
ESC TV Interview - A Pre-Specified Meta-Analysis of DELIVER and EMPEROR-Preserved.
Video

Access the full session

Session thumbnail
Hot Line: Heart Failure
Video

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December 2022 16:06 CET
You may be interested in
thumbnail
Congress Presentation
Eligibility for acetazolamide in real-world acute heart failure patients
22 May 2023
thumbnail
Congress Presentation
Pearls for the cardiac intensivist: diagnosis and treatment of common cardiovascular emergencies - discussion.
19 March 2022
thumbnail
Webinar
Early initiation of SGLT-2 inhibitors after acute decompensated heart failure
26 October 2022
thumbnail
Congress Presentation
Acetazolamide as an adjunct to loop diuretics in decongesting patients with acute decompensated heart failure: a systematic review and meta-analysis
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources